Advice for healthcare professionals on the reclassification of codeine linctus to a prescription-only medicine (POM), following a public consultation. This content is
Use the original MHRA report for the full story and treat this page as a linked clinical update rather than a republished article.
ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.